18.06.2009
We congratulate our enterprise’s work-force on a high estimation of its scientific work

XII World congress of the International Association of Photodynamic therapy (IPA) took place in Seattle during from June, 11 till June, 15th 2009. On the congress experts of RUE «Belmedpreparaty» had been presented two reports, which were devoted to results of experimental and clinical researches of a medical product Photolon: «THE DIRECT AND REMOTE RESULTS OF THE ESTIMATION OF EFFICIENCY AND SAFETY OF THE PHOTOSENSITIZER OF PHOTOLON: 7 YEARS OF EXPERIENCE OF CLINICAL APPLICATION», «ESTIMATION OF TOXICOLOGICAL PROPERTIES AND PHOTODYNAMIC ACTIVITY OF OINTMENT OF PHOTOLON. THE EXPERIMENTAL RESEARCH».

The international scientific committee has been recognized the report «THE DIRECT AND REMOTE RESULTS OF THE ESTIMATION OF EFFICIENCY AND SAFETY OF THE PHOTOSENSITIZER OF PHOTOLON: 7 YEARS OF EXPERIENCE OF CLINICAL APPLICATION» as the best message of the congress.

The original medical product Photolon which is developed and let out at Belarus enterprise RUE «Belmedpreparaty» now is one of the most perspective photosensitizers for photodynamic therapy – the modern approach to treatment of cancerous growth and of some not oncological diseases. The Belarus experts and their Russian colleagues now save up a certain experience on application of a medical product Photolon in treatment of patients with tumours of a leather and mucous membranes of hollow organs, some ophthalmologic diseases, of some precancer pathologies. Results of the earlier researches already received a high estimation of the international scientific community. Now experimental and clinical researches of a preparation Photolon in Belarus go on with the purpose of expansion of area of its medical application proceed.